Miquel Kraft Carre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Miquel Kraft Carre has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Eloy Espin-Basany
Chief of Colorectal Surgery Unit, Hospital Valle de Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
10 shared publications - Gianluca Pellino
Colorectal Surgery, Vall d'Hebron University Hospital Universitat Autonoma de Barcelona UAB Barcelona Spain
10 shared publications - Alejandro Solís-Peña
Colorectal Surgery, Department of General and Digestive Surgery, Vall d’Hebron University Hospital, Barcelona, Spain
4 shared publications - Marc Martí Gallostra
Department of General Surgery Colorectal Surgery Unit Hospital Universitari Vall d’Hebron Universitat Autònoma de Barcelona Barcelona Spain
4 shared publications Gianluca Pellino
Vall d’Hebron University Hospital, Universitat Autonoma de Barcelona UAB, Barcelona, Spain
3 shared publications- Oscar Cano-Valderrama
Complejo Hospitalario Universitario de Vigo, 36312 Vigo, Spain
3 shared publications
Latest Publications
- Open Access
- 11 October 2026
- Published by Springer Nature in Techniques in Coloproctology
TAMIS repair within a structured multimodal management pathway for colorectal anastomotic leaks: surgical technique and outcomes
Aim: We describe the transanal minimally invasive surgerical (TAMIS) procedure for the elective repair of colorectal anastomotic leaks (AL) within a structured management pathway based on early leak detection and selective adjunctive therapy. We also report the clinical outcomes of this multimodal approach, along with an operative video illustrating the surgical technique step by step. Method: Data on patients who underwent TAMIS for AL at our centre were collected. The operative video demonstrates each step of the technique, highlighting its advantages and feasibility. Results: Thirteen patients underwent the TAMIS approach to treat colorectal AL between 2016 and 2024, with a median age of 55 (range: 14–84) years. Anastomosis was repaired and rescued in 12 (92.31%) patients. The median length of hospital stay was 20 (14–38) days. All but one patient (92.31%) with long-term anastomotic healing achieved closed ileostomies. Conclusions: Within a structured multimodal management pathway, TAMIS is a safe and feasible option for selected patients with colorectal anastomotic leaks. Limitations: This is a single-centre study with a small sample size.
- 11 October 2026
- Published by Springer Nature in Techniques in Coloproctology
Open AccessTAMIS repair within a structured multimodal management pathway for colorectal anastomotic leaks: surgical technique and outcomes
Aim: We describe the transanal minimally invasive surgerical (TAMIS) procedure for the elective repair of colorectal anastomotic leaks (AL) within a structured management pathway based on early leak detection and selective adjunctive therapy. We also report the clinical outcomes of this multimodal approach, along with an operative video illustrating the surgical technique step by step. Method: Data on patients who underwent TAMIS for AL at our centre were collected. The operative video demonstrates each step of the technique, highlighting its advantages and feasibility. Results: Thirteen patients underwent the TAMIS approach to treat colorectal AL between 2016 and 2024, with a median age of 55 (range: 14–84) years. Anastomosis was repaired and rescued in 12 (92.31%) patients. The median length of hospital stay was 20 (14–38) days. All but one patient (92.31%) with long-term anastomotic healing achieved closed ileostomies. Conclusions: Within a structured multimodal management pathway, TAMIS is a safe and feasible option for selected patients with colorectal anastomotic leaks. Limitations: This is a single-centre study with a small sample size.
- 12 August 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (8) , e70587
Robotic Heineke–Mikulicz strictureplasty for ileal Crohn's disease—A video vignette
- 12 August 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (8) , e70587
Robotic Heineke–Mikulicz strictureplasty for ileal Crohn's disease—A video vignette
- Open Access
- 29 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14645-14655
Bowel dysfunction (LARS) and quality of life after chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab, N0, M0 rectal cancer: the TAUTEM randomized clinical trial
Background: Bowel dysfunction and quality of life (QoL) are key determinants of long-term outcomes after treatment for localized rectal cancer (cT2–cT3a–b, N0, M0). Total mesorectal excision (TME) provides effective oncologic control but may cause substantial functional impairment. Organ-preserving strategies combining chemoradiotherapy with local excision may improve functional outcomes, yet long-term patient-reported data remain limited. Materials and Methods: TAUTEM is a multicenter, prospective, open-label, phase 3, randomized, noninferiority trial comparing chemoradiotherapy followed by transanal endoscopic microsurgery (CRT–TEM) with standard TME in patients with T2–T3ab, N0, M0 rectal cancer. Long-term bowel function was assessed using the Low Anterior Resection Syndrome (LARS) score ≥24 months after definitive treatment. Quality of life (QoL) was evaluated using the EORTC QLQ-C30, QLQ-CR38, and the Karnofsky Performance Status at baseline and after treatment. Analyses were conducted in the modified intention-to-treat and per-protocol populations. Results: Of 173 randomized patients, 162 were included in the modified intention-to-treat analysis (81 per group). Long-term LARS assessment was available for 96 of 102 eligible patients (94%) at a median follow-up of 87.5 months. Global QoL was higher after CRT–TEM than after TME (median 83.3 vs 66.7; P = 0.02). Permanent stoma rates were lower following CRT–TEM than after TME (7.4% vs 28.4%). Major LARS occurred less frequently after CRT–TEM than after TME (7.7% vs 36.4%; P = 0.001), with higher rates of no LARS (80.8% vs 47.7%; P = 0.001). Item-level outcomes (frequency, urgency, clustering, and flatus incontinence) consistently favored CRT–TEM. Conclusions: CRT–TEM was associated with substantially less long-term bowel dysfunction and superior QoL compared with TME, together with markedly fewer permanent stomas. These findings support organ-preserving strategies for selected patients with cT2–cT3a–b, N0, M0 rectal cancer.
- 29 July 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14645-14655
Open AccessBowel dysfunction (LARS) and quality of life after chemoradiotherapy and local excision versus total mesorectal excision in T2–T3ab, N0, M0 rectal cancer: the TAUTEM randomized clinical trial
Background: Bowel dysfunction and quality of life (QoL) are key determinants of long-term outcomes after treatment for localized rectal cancer (cT2–cT3a–b, N0, M0). Total mesorectal excision (TME) provides effective oncologic control but may cause substantial functional impairment. Organ-preserving strategies combining chemoradiotherapy with local excision may improve functional outcomes, yet long-term patient-reported data remain limited. Materials and Methods: TAUTEM is a multicenter, prospective, open-label, phase 3, randomized, noninferiority trial comparing chemoradiotherapy followed by transanal endoscopic microsurgery (CRT–TEM) with standard TME in patients with T2–T3ab, N0, M0 rectal cancer. Long-term bowel function was assessed using the Low Anterior Resection Syndrome (LARS) score ≥24 months after definitive treatment. Quality of life (QoL) was evaluated using the EORTC QLQ-C30, QLQ-CR38, and the Karnofsky Performance Status at baseline and after treatment. Analyses were conducted in the modified intention-to-treat and per-protocol populations. Results: Of 173 randomized patients, 162 were included in the modified intention-to-treat analysis (81 per group). Long-term LARS assessment was available for 96 of 102 eligible patients (94%) at a median follow-up of 87.5 months. Global QoL was higher after CRT–TEM than after TME (median 83.3 vs 66.7; P = 0.02). Permanent stoma rates were lower following CRT–TEM than after TME (7.4% vs 28.4%). Major LARS occurred less frequently after CRT–TEM than after TME (7.7% vs 36.4%; P = 0.001), with higher rates of no LARS (80.8% vs 47.7%; P = 0.001). Item-level outcomes (frequency, urgency, clustering, and flatus incontinence) consistently favored CRT–TEM. Conclusions: CRT–TEM was associated with substantially less long-term bowel dysfunction and superior QoL compared with TME, together with markedly fewer permanent stomas. These findings support organ-preserving strategies for selected patients with cT2–cT3a–b, N0, M0 rectal cancer.
- Open Access
Early-Onset Colorectal Cancer: Clinicopathological Features and Surgical Outcomes in Patients Treated with Curative Intent at a Tertiary Center
Background: The incidence of early-onset colorectal cancer (EOCRC) has increased worldwide and now represents approximately 10% of colorectal cancers in high-income countries. EOCRC is frequently associated with advanced pathological features, although its clinical behavior and optimal management remain incompletely defined. Methods: We performed a retrospective single-center study including 88 consecutive patients aged ≤50 years who underwent curative-intent colorectal cancer resection between January 2019 and December 2023 at a tertiary referral center. Perioperative outcomes, pathological characteristics, and recurrence patterns were analyzed. Results: The median age was 44 years, and 67% of tumors were located in the colon. Pathological nodal involvement (pN+) was observed in 47.7% of patients, with a high prevalence of adverse features including perineural invasion (62.5%), tumor budding (17.0%), and tumor deposits (15.9%). Minimally invasive surgery was performed in 79% of patients and was associated with shorter hospital stay without increased postoperative morbidity (19.3%). During a median follow-up of 31.3 months [IQR 21.6–44.6], recurrence occurred in 40 patients (45.5%) and was predominantly distant (75.0%). Among patients with recurrence, 21 (52.5%) underwent surgical reintervention, most commonly hepatic and pulmonary resections. Rectal cancer was associated with higher rates of stoma formation and major postoperative complications compared to colon cancer. Conclusions: EOCRC is characterized by a high prevalence of adverse pathological features and a substantial rate of distant recurrence. However, a relevant proportion of recurrences remains amenable to surgical treatment in selected patients. Management in a specialized tertiary center allows achievement of high-quality surgical outcomes and supports an aggressive multidisciplinary approach.
Open AccessEarly-Onset Colorectal Cancer: Clinicopathological Features and Surgical Outcomes in Patients Treated with Curative Intent at a Tertiary Center
Background: The incidence of early-onset colorectal cancer (EOCRC) has increased worldwide and now represents approximately 10% of colorectal cancers in high-income countries. EOCRC is frequently associated with advanced pathological features, although its clinical behavior and optimal management remain incompletely defined. Methods: We performed a retrospective single-center study including 88 consecutive patients aged ≤50 years who underwent curative-intent colorectal cancer resection between January 2019 and December 2023 at a tertiary referral center. Perioperative outcomes, pathological characteristics, and recurrence patterns were analyzed. Results: The median age was 44 years, and 67% of tumors were located in the colon. Pathological nodal involvement (pN+) was observed in 47.7% of patients, with a high prevalence of adverse features including perineural invasion (62.5%), tumor budding (17.0%), and tumor deposits (15.9%). Minimally invasive surgery was performed in 79% of patients and was associated with shorter hospital stay without increased postoperative morbidity (19.3%). During a median follow-up of 31.3 months [IQR 21.6–44.6], recurrence occurred in 40 patients (45.5%) and was predominantly distant (75.0%). Among patients with recurrence, 21 (52.5%) underwent surgical reintervention, most commonly hepatic and pulmonary resections. Rectal cancer was associated with higher rates of stoma formation and major postoperative complications compared to colon cancer. Conclusions: EOCRC is characterized by a high prevalence of adverse pathological features and a substantial rate of distant recurrence. However, a relevant proportion of recurrences remains amenable to surgical treatment in selected patients. Management in a specialized tertiary center allows achievement of high-quality surgical outcomes and supports an aggressive multidisciplinary approach.
- Open Access
- 27 March 2026
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 30 (1) , 48
Safe discharge on the second postoperative day after major colorectal surgery: a decision-making strategy based on quantitative serological data
Background: Enhanced Recovery After Surgery (ERAS) has enabled early patient discharge, but reliable biomarkers are needed to support safe early discharges. C-reactive protein levels have been reported as good markers for early anastomotic leak detection and also for overall complications, but there is no consensus yet on its quantification nor day of analysis. Objective: This study aimed to determine the C-reactive protein cutoff values at postoperative day (POD) 2–4 associated with the lowest risk of postoperative complications. Design: Single-center, retrospective study. Settings: Tertiary hospital. Patients: Patients operated on between 2019 and 2022. Interventions: Surgery for colorectal cancer. Main outcome measures: C-reactive protein on postoperative days 2–4 and the delta difference between postoperative days 3 and 2 were measured, identifying the best cutoff value for each postoperative complication. Receiver-operating characteristics curves were generated and the area under the curve was analyzed for each postoperative day measurement. Results: A total of 434 patients were included, median age was 72 (62–80) years. On postoperative day-2, the cutoff values for overall morbidity, surgical complications, medical complications, and anastomotic leak were 139.2 mg/L, 144.4 mg/L, 140 mg/L, and 170 mg/L, respectively. POD3 and 2 were both safe (area under the curve of 0.7507 and 0.7466, respectively). The negative predictive values using a C-reactive protein POD2 cutoff value of 140 mg/L were 80.6%, 91.5%, 87.6%, and 98.6% for global, medical, surgical complications, and anastomotic leak, respectively. Limitations: Retrospective study. Conclusions: Carefully selected, motivated, and clinically suitable patients could be offered discharge on POD2 if their C-reactive protein levels are below 140 mg/L, with a very high negative predictive value for anastomotic leak and other postoperative complications. This decision should be made in collaboration with patients, considering clinical assessment and logistic factors.
- 27 March 2026
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 30 (1) , 48
Open AccessSafe discharge on the second postoperative day after major colorectal surgery: a decision-making strategy based on quantitative serological data
Background: Enhanced Recovery After Surgery (ERAS) has enabled early patient discharge, but reliable biomarkers are needed to support safe early discharges. C-reactive protein levels have been reported as good markers for early anastomotic leak detection and also for overall complications, but there is no consensus yet on its quantification nor day of analysis. Objective: This study aimed to determine the C-reactive protein cutoff values at postoperative day (POD) 2–4 associated with the lowest risk of postoperative complications. Design: Single-center, retrospective study. Settings: Tertiary hospital. Patients: Patients operated on between 2019 and 2022. Interventions: Surgery for colorectal cancer. Main outcome measures: C-reactive protein on postoperative days 2–4 and the delta difference between postoperative days 3 and 2 were measured, identifying the best cutoff value for each postoperative complication. Receiver-operating characteristics curves were generated and the area under the curve was analyzed for each postoperative day measurement. Results: A total of 434 patients were included, median age was 72 (62–80) years. On postoperative day-2, the cutoff values for overall morbidity, surgical complications, medical complications, and anastomotic leak were 139.2 mg/L, 144.4 mg/L, 140 mg/L, and 170 mg/L, respectively. POD3 and 2 were both safe (area under the curve of 0.7507 and 0.7466, respectively). The negative predictive values using a C-reactive protein POD2 cutoff value of 140 mg/L were 80.6%, 91.5%, 87.6%, and 98.6% for global, medical, surgical complications, and anastomotic leak, respectively. Limitations: Retrospective study. Conclusions: Carefully selected, motivated, and clinically suitable patients could be offered discharge on POD2 if their C-reactive protein levels are below 140 mg/L, with a very high negative predictive value for anastomotic leak and other postoperative complications. This decision should be made in collaboration with patients, considering clinical assessment and logistic factors.
- 22 January 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (2) , e70376
Step‐by‐step demonstration of Hotokezaka strictureplasty for Crohn's disease: A video vignette
- 22 January 2026
- Published by Wiley in Colorectal Disease
- Vol. 28 (2) , e70376
Step‐by‐step demonstration of Hotokezaka strictureplasty for Crohn's disease: A video vignette
- Open Access
Conditional Survival in Patients with Locally Advanced Rectal Cancer and Pathologic Complete Response: Results from an Observational Retrospective Multicenter Long-Term Follow-Up Study
Introduction/Background: Patients with locally advanced rectal cancer (LARC) with pathological complete response (pCR) after neoadjuvant chemo-radiotherapy (NCRT) are a privileged group because of the favorable progression of their disease. However, their follow-up patterns after surgery are similar to those of other groups with worse prognosis, with the consequent psychological and economic impact. Methods: This is a retrospective observational multicenter study with data obtained from the Spanish Rectal Cancer Project. Patients with LARC who underwent surgery with curative intent after NCRT and achieved pCR were selected. The last follow-up update was conducted in December 2021. A conditional survival model was used to analyze oncological outcomes during follow-up. Recurrence-free survival (RFS) was analyzed for the entire cohort of patients and for those who survived at one, two, and three years. Results: A total of 815 patients from 32 hospitals were included. Their mean age was 65.1 years, and 36.1% of them were women. Of the 815 patients, 35 died or experienced recurrence (local or systemic) in the first postoperative year, and 780 were included in the conditional survival analysis one year after surgery. The probability of RFS at 5 years was 86.5% in the whole cohort and 89.4%, 92.9%, and 95.2% for survivors at one, two, and three years, respectively. The probability of recurrence in these same groups was 6.5%, 4.3%, 1.8%, and 0.6%. Conclusions: Follow-up of patients with LARC and pCR after NCRT followed by surgery could be adapted based on conditional survival data showing that the probability of RFS increases as patients remain recurrence-free, and recurrences more than 3 years after treatment are exceptional.
Open AccessConditional Survival in Patients with Locally Advanced Rectal Cancer and Pathologic Complete Response: Results from an Observational Retrospective Multicenter Long-Term Follow-Up Study
Introduction/Background: Patients with locally advanced rectal cancer (LARC) with pathological complete response (pCR) after neoadjuvant chemo-radiotherapy (NCRT) are a privileged group because of the favorable progression of their disease. However, their follow-up patterns after surgery are similar to those of other groups with worse prognosis, with the consequent psychological and economic impact. Methods: This is a retrospective observational multicenter study with data obtained from the Spanish Rectal Cancer Project. Patients with LARC who underwent surgery with curative intent after NCRT and achieved pCR were selected. The last follow-up update was conducted in December 2021. A conditional survival model was used to analyze oncological outcomes during follow-up. Recurrence-free survival (RFS) was analyzed for the entire cohort of patients and for those who survived at one, two, and three years. Results: A total of 815 patients from 32 hospitals were included. Their mean age was 65.1 years, and 36.1% of them were women. Of the 815 patients, 35 died or experienced recurrence (local or systemic) in the first postoperative year, and 780 were included in the conditional survival analysis one year after surgery. The probability of RFS at 5 years was 86.5% in the whole cohort and 89.4%, 92.9%, and 95.2% for survivors at one, two, and three years, respectively. The probability of recurrence in these same groups was 6.5%, 4.3%, 1.8%, and 0.6%. Conclusions: Follow-up of patients with LARC and pCR after NCRT followed by surgery could be adapted based on conditional survival data showing that the probability of RFS increases as patients remain recurrence-free, and recurrences more than 3 years after treatment are exceptional.
- Open Access
- 11 August 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (10) , 1920-1926
Long-term comparative outcomes after ileocecal resection for inflammatory versus complicated Crohn’s disease. A multicenter, retrospective study (Crohn's-Urg)
- 11 August 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (10) , 1920-1926
Open AccessLong-term comparative outcomes after ileocecal resection for inflammatory versus complicated Crohn’s disease. A multicenter, retrospective study (Crohn's-Urg)
- Open Access
- 30 September 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (11) , 6982-6984
Correction: Cost-efectiveness of robotic vs laparoscopic distal pancreatectomy. Results from the national prospective trial ROBOCOSTES
- 30 September 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (11) , 6982-6984
Open AccessCorrection: Cost-efectiveness of robotic vs laparoscopic distal pancreatectomy. Results from the national prospective trial ROBOCOSTES